ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Ticker SymbolASPI
Company nameASP Isotopes Inc
IPO dateNov 10, 2022
CEOMr. Paul Elliot Mann
Number of employees136
Security typeOrdinary Share
Fiscal year-endNov 10
Address601 Pennsylvania Avenue Nw
CityWASHINGTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code20004
Phone12027562245
Websitehttps://aspisotopes.com/
Ticker SymbolASPI
IPO dateNov 10, 2022
CEOMr. Paul Elliot Mann
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data